Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Fritah, H."'
Autor:
Kandalaft, L., Fritah, H., Graciotti, M., Chiang, C., Petremand, R., Guillaume, P., Schmidt, J., Stevenson, B., Gfeller, D., Harari, A.
Publikováno v:
In Immuno-Oncology and Technology December 2022 16 Supplement 1
Autor:
Benkhoucha M; Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, 1211 Geneva, Switzerland., Tran NL; Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, 1211 Geneva, Switzerland., Senoner I; Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, 1211 Geneva, Switzerland., Breville G; Department of Clinical Neurosciences, Division of Neurology, University Hospital of Geneva, 1205 Geneva, Switzerland.; Center for Neuroinflammation and Experimental Therapeutics, Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Fritah H; Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, 1211 Geneva, Switzerland., Migliorini D; Brain Tumor and Immune Cell Engineering Laboratory, Department of Medicine, Faculty of Medicine, University of Geneva, 1211 Geneva, Switzerland.; Department of Oncology, Unit of Neuro-Oncology, University Hospital of Geneva, 1205 Geneva, Switzerland., Dutoit V; Brain Tumor and Immune Cell Engineering Laboratory, Department of Medicine, Faculty of Medicine, University of Geneva, 1211 Geneva, Switzerland., Lalive PH; Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, 1211 Geneva, Switzerland.; Department of Clinical Neurosciences, Division of Neurology, University Hospital of Geneva, 1205 Geneva, Switzerland.
Publikováno v:
Biomedicines [Biomedicines] 2023 Nov 23; Vol. 11 (12). Date of Electronic Publication: 2023 Nov 23.
Autor:
Fritah H; Ludwig Institute for Cancer Research, Lausanne Branch, and Department of Oncology, University Hospital of Lausanne (CHUV) and University of Lausanne (UNIL), Lausanne, 1011, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland., Graciotti M; Ludwig Institute for Cancer Research, Lausanne Branch, and Department of Oncology, University Hospital of Lausanne (CHUV) and University of Lausanne (UNIL), Lausanne, 1011, Switzerland.; Center of Experimental Therapeutics, Department of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland., Lai-Lai Chiang C; Ludwig Institute for Cancer Research, Lausanne Branch, and Department of Oncology, University Hospital of Lausanne (CHUV) and University of Lausanne (UNIL), Lausanne, 1011, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland., Huguenin-Bergenat AL; Ludwig Institute for Cancer Research, Lausanne Branch, and Department of Oncology, University Hospital of Lausanne (CHUV) and University of Lausanne (UNIL), Lausanne, 1011, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland., Petremand R; Ludwig Institute for Cancer Research, Lausanne Branch, and Department of Oncology, University Hospital of Lausanne (CHUV) and University of Lausanne (UNIL), Lausanne, 1011, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland., Ahmed R; Ludwig Institute for Cancer Research, Lausanne Branch, and Department of Oncology, University Hospital of Lausanne (CHUV) and University of Lausanne (UNIL), Lausanne, 1011, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland., Guillaume P; Ludwig Institute for Cancer Research, Lausanne Branch, and Department of Oncology, University Hospital of Lausanne (CHUV) and University of Lausanne (UNIL), Lausanne, 1011, Switzerland.; Center of Experimental Therapeutics, Department of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland., Schmidt J; Ludwig Institute for Cancer Research, Lausanne Branch, and Department of Oncology, University Hospital of Lausanne (CHUV) and University of Lausanne (UNIL), Lausanne, 1011, Switzerland.; Center of Experimental Therapeutics, Department of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland., Stevenson BJ; Ludwig Institute for Cancer Research, Lausanne Branch, and Department of Oncology, University Hospital of Lausanne (CHUV) and University of Lausanne (UNIL), Lausanne, 1011, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland.; SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland., Gfeller D; Ludwig Institute for Cancer Research, Lausanne Branch, and Department of Oncology, University Hospital of Lausanne (CHUV) and University of Lausanne (UNIL), Lausanne, 1011, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland.; SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland., Harari A; Ludwig Institute for Cancer Research, Lausanne Branch, and Department of Oncology, University Hospital of Lausanne (CHUV) and University of Lausanne (UNIL), Lausanne, 1011, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland., Kandalaft LE; Ludwig Institute for Cancer Research, Lausanne Branch, and Department of Oncology, University Hospital of Lausanne (CHUV) and University of Lausanne (UNIL), Lausanne, 1011, Switzerland.; Center of Experimental Therapeutics, Department of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.; Agora Cancer Research Center, Lausanne, Switzerland.
Publikováno v:
IScience [iScience] 2023 Feb 27; Vol. 26 (4), pp. 106288. Date of Electronic Publication: 2023 Feb 27 (Print Publication: 2023).
Autor:
Fritah H; Department of Oncology, Centre Hospitalier Universitaire Vaudois (CHUV), Ludwig Institute for Cancer Research, University of Lausanne, CH-1011 Lausanne, Switzerland. Electronic address: Hajer.Fritah@chuv.ch., Rovelli R; Department of Oncology, Centre Hospitalier Universitaire Vaudois (CHUV), Ludwig Institute for Cancer Research, University of Lausanne, CH-1011 Lausanne, Switzerland. Electronic address: raphael.rovelli@unil.ch., Chiang CL; Department of Oncology, Centre Hospitalier Universitaire Vaudois (CHUV), Ludwig Institute for Cancer Research, University of Lausanne, CH-1011 Lausanne, Switzerland. Electronic address: Lai-Lai-Cheryl.Chiang@chuv.ch., Kandalaft LE; Department of Oncology, Centre Hospitalier Universitaire Vaudois (CHUV), Ludwig Institute for Cancer Research, University of Lausanne, CH-1011 Lausanne, Switzerland; Center of Experimental Therapeutics, Department of Oncology, CHUV, CH-1011 Lausanne, Switzerland. Electronic address: Lana.Kandalaft@chuv.ch.
Publikováno v:
Cancer treatment reviews [Cancer Treat Rev] 2022 May; Vol. 106, pp. 102383. Date of Electronic Publication: 2022 Mar 24.
Autor:
杨镇洲1
Publikováno v:
Journal of Modern Medicine & Health. 10/30/2024, Vol. 40 Issue 20, p3421-3431. 6p.
Autor:
Bojarska, Joanna1 (AUTHOR) joanna.bojarska@p.lodz.pl, Wolf, Wojciech M.1 (AUTHOR)
Publikováno v:
Cancers. Oct2024, Vol. 16 Issue 19, p3254. 33p.
Autor:
Yao, Shuxi1 (AUTHOR) yaoshuxi@hust.edu.cn, Liu, Xinyue1 (AUTHOR), Feng, Yanqi1 (AUTHOR), Li, Yiming1 (AUTHOR), Xiao, Xiangtian1 (AUTHOR), Han, Yuelin1 (AUTHOR), Xia, Shu1 (AUTHOR) xiashutj@hust.edu.cn
Publikováno v:
International Journal of Molecular Sciences. Aug2024, Vol. 25 Issue 16, p9101. 28p.
Autor:
Sheikhlary, Sara1 (AUTHOR) sheikhlary@arizona.edu, Lopez, David Humberto2 (AUTHOR) davidlopez3@arizona.edu, Moghimi, Sophia2 (AUTHOR) sophiam2@arizona.edu, Sun, Bo2 (AUTHOR) sheikhlary@arizona.edu
Publikováno v:
Biomolecules (2218-273X). Apr2024, Vol. 14 Issue 4, p503. 38p.
Autor:
Samudrala, Madhav1 (AUTHOR), Dhaveji, Sindhusri2 (AUTHOR), Savsani, Kush3 (AUTHOR), Dakshanamurthy, Sivanesan4 (AUTHOR) sd233@georgetown.edu
Publikováno v:
Bioengineering (Basel). Apr2024, Vol. 11 Issue 4, p322. 25p.
Autor:
Huang, Xiaoyu1 (AUTHOR) xyhuang0701@163.com, Zhu, Xiaolong1 (AUTHOR) 2023112025090@stu.hznu.edu.cn, Yang, Huan1 (AUTHOR) yhnpc1029@163.com, Li, Qinyi1 (AUTHOR) liqinyi2000620@163.com, Gai, Lizhi2 (AUTHOR) lizhigai@hznu.edu.cn, Sui, Xinbing1 (AUTHOR) hzzju@hznu.edu.cn, Lu, Hua2 (AUTHOR) hualu@hznu.edu.cn, Feng, Jiao1 (AUTHOR) hualu@hznu.edu.cn
Publikováno v:
Molecules. Apr2024, Vol. 29 Issue 7, p1462. 25p.